ScholarIQanswers from OpenAlex & ORCID
Jeffrey Settleman
ResearcherPublications, citations & collaboration network
Jeffrey Settleman is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Jeffrey Settleman have?
ScholarIQindexed works
Jeffrey Settleman has 424 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Jeffrey Settleman have?
ScholarIQcitation count
Jeffrey Settleman has 40,730 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Jeffrey Settleman?
ScholarIQh-index
Jeffrey Settleman has an h-index of 82 in OpenAlex.
What is the i10-index of Jeffrey Settleman?
ScholarIQi10-index
Jeffrey Settleman has an i10-index of 148 in OpenAlex.
What is the ORCID of Jeffrey Settleman?
ScholarIQorcid
The ORCID for Jeffrey Settleman is on the source record.
What is the OpenAlex record for Jeffrey Settleman?
ScholarIQopenalex
The OpenAlex for Jeffrey Settleman is on the source record.
What are the most-cited papers on Jeffrey Settleman?
ScholarIQmost cited works
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Eunice L. Kwak, Yung‐Jue Bang, D. Ross Camidge, Alice T. Shaw, Benjamin Solomon, Robert G. Maki, Sai‐Hong Ignatius Ou, Bruce J. Dezube, Pasi A. Jänne, Daniel B. Costa, Marileila Varella‐Garcia, Woo Ho Kim, Thomas J. Lynch, Panos Fidias, Hannah Stubbs, Jeffrey A. Engelman, Lecia V. Sequist, Weiwei Tan, Leena Gandhi, Mari Mino–Kenudson, Greg C. G. Wei, S. Martin Shreeve, Mark J. Ratain, Jeffrey Settleman, James G. Christensen, Daniel A. Haber, Keith D. Wilner, Ravi Salgia, Geoffrey I. Shapiro, Jeffrey W. Clark, A. John Iafrate
Systematic identification of genomic markers of drug sensitivity in cancer cells
Mathew J. Garnett, Elena J. Edelman, Sonja J. Heidorn, Chris Greenman, Anahita Dastur, King Wai Lau, Patricia Greninger, I. Richard Thompson, Xi Luo, Jorge Soares, Qingsong Liu, Francesco Iorio, Didier Surdez, Li Chen, Randy Milano, Graham R. Bignell, Ah Ting Tam, Helen Davies, Jesse A. Stevenson, Syd Barthorpe, Stephen Lutz, Fiona Kogera, Karl Lawrence, Anne McLaren-Douglas, Xeni Mitropoulos, Tatiana Mironenko, Helen Thi, Laura Richardson, Wenjun Zhou, Frances Jewitt, Tinghu Zhang, Patrick O’Brien, Jessica L. Boisvert, Stacey Price, Wooyoung Hur, Wanjuan Yang, Xianming Deng, Adam P. Butler, Hwan Geun Choi, Jae Won Chang, José Baselga, Ivan Stamenkovic, Jeffrey A. Engelman, Sreenath V. Sharma, Olivier Delattre, Julio Sáez-Rodríguez, Nathanael S. Gray, Jeffrey Settleman, P. Andrew Futreal, Daniel A. Haber, Michael R. Stratton, Sridhar Ramaswamy, Ultan McDermott, Cyril H. Benes
Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor <i>EML4-ALK</i>
Alice T. Shaw, Beow Y. Yeap, Mari Mino–Kenudson, Subba R. Digumarthy, Daniel B. Costa, Rebecca S. Heist, Benjamin Solomon, Hannah Stubbs, Sonal Admane, Ultan McDermott, Jeffrey Settleman, Susumu Kobayashi, Eugene J. Mark, Scott J. Rodig, Lucian R. Chirieac, Eunice L. Kwak, Thomas J. Lynch, A. John Iafrate
Detection of Mutations in <i>EGFR</i> in Circulating Lung-Cancer Cells
Shyamala Maheswaran, Lecia V. Sequist, Sunitha Nagrath, Lindsey Ulkus, Brian W. Brannigan, Chey V. Collura, Elizabeth K. Inserra, Sven Diederichs, A. John Iafrate, Daphne W. Bell, Subba R. Digumarthy, Alona Muzikansky, Daniel Irimia, Jeffrey Settleman, Ronald G. Tompkins, Thomas J. Lynch, Mehmet Toner, Daniel A. Haber
EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of <i>BRAF</i> -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib
Ryan B. Corcoran, Hiromichi Ebi, Alexa B. Turke, Erin M. Coffee, Michiya Nishino, Alexandria P. Cogdill, Ronald D. Brown, Patricia Della Pelle, Dora Dias‐Santagata, Kenneth E. Hung, Keith T. Flaherty, Adriano Piris, Jennifer A. Wargo, Jeffrey Settleman, Mari Mino–Kenudson, Jeffrey A. Engelman